BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 30965124)

  • 1. Natural history of dry eye disease: Perspectives from inter-ethnic comparison studies.
    Wang MTM; Craig JP
    Ocul Surf; 2019 Jul; 17(3):424-433. PubMed ID: 30965124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Asian ethnic predisposition to dry eye disease in a pediatric population.
    Kim JS; Wang MTM; Craig JP
    Ocul Surf; 2019 Jan; 17(1):70-77. PubMed ID: 30219270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ethnic differences between the Asian and Caucasian ocular surface: A co-located adult migrant population cohort study.
    Craig JP; Lim J; Han A; Tien L; Xue AL; Wang MTM
    Ocul Surf; 2019 Jan; 17(1):83-88. PubMed ID: 30253249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of blinking on ocular surface and tear film parameters.
    Wang MTM; Tien L; Han A; Lee JM; Kim D; Markoulli M; Craig JP
    Ocul Surf; 2018 Oct; 16(4):424-429. PubMed ID: 29883739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective optical assessment of tear-film quality dynamics in patients with meibomian gland dysfunction and aqueous-deficient dry eye optical quality changes in different dry eye subtypes.
    Ye F; Jiang F; Lu Y; Xue CY; Zhu XM; Wu Y; Huang ZP
    Indian J Ophthalmol; 2019 May; 67(5):599-603. PubMed ID: 31007216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rethinking dry eye disease: a perspective on clinical implications.
    Bron AJ; Tomlinson A; Foulks GN; Pepose JS; Baudouin C; Geerling G; Nichols KK; Lemp MA
    Ocul Surf; 2014 Apr; 12(2 Suppl):S1-31. PubMed ID: 24725379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of incomplete blinking as a measurement of dry eye disease.
    Jie Y; Sella R; Feng J; Gomez ML; Afshari NA
    Ocul Surf; 2019 Jul; 17(3):440-446. PubMed ID: 31152804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blink Test enhances ability to screen for dry eye disease.
    Wolffsohn JS; Craig JP; Vidal-Rohr M; Huarte ST; Ah Kit L; Wang M
    Cont Lens Anterior Eye; 2018 Oct; 41(5):421-425. PubMed ID: 29958779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the Predisposition of the Asian Eye to Development of Dry Eye.
    Craig JP; Wang MT; Kim D; Lee JM
    Ocul Surf; 2016 Jul; 14(3):385-92. PubMed ID: 27143647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic risk factors of dry eye disease subtypes: A New Zealand cross-sectional study.
    Wang MTM; Vidal-Rohr M; Muntz A; Diprose WK; Ormonde SE; Wolffsohn JS; Craig JP
    Ocul Surf; 2020 Jul; 18(3):374-380. PubMed ID: 32311433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ageing and the natural history of dry eye disease: A prospective registry-based cross-sectional study.
    Wang MTM; Muntz A; Lim J; Kim JS; Lacerda L; Arora A; Craig JP
    Ocul Surf; 2020 Oct; 18(4):736-741. PubMed ID: 32758530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incomplete blinking: exposure keratopathy, lid wiper epitheliopathy, dry eye, refractive surgery, and dry contact lenses.
    McMonnies CW
    Cont Lens Anterior Eye; 2007 Mar; 30(1):37-51. PubMed ID: 17251052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of duration of contact lens wear on the structure and function of the meibomian glands.
    Alghamdi WM; Markoulli M; Holden BA; Papas EB
    Ophthalmic Physiol Opt; 2016 Mar; 36(2):120-31. PubMed ID: 26890701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Semifluorinated Alkane Eye Drops for Treatment of Dry Eye Disease Due to Meibomian Gland Disease.
    Steven P; Augustin AJ; Geerling G; Kaercher T; Kretz F; Kunert K; Menzel-Severing J; Schrage N; Schrems W; Krösser S; Beckert M; Messmer EM
    J Ocul Pharmacol Ther; 2017 Nov; 33(9):678-685. PubMed ID: 28922088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial.
    Craig JP; Muntz A; Wang MTM; Luensmann D; Tan J; Trave Huarte S; Xue AL; Jones L; Willcox MDP; Wolffsohn JS
    Ocul Surf; 2021 Apr; 20():62-69. PubMed ID: 33401019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of dry eye disease in the UK: The Aston dry eye study.
    Vidal-Rohr M; Craig JP; Davies LN; Wolffsohn JS
    Cont Lens Anterior Eye; 2023 Jun; 46(3):101837. PubMed ID: 37003925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter Cross-sectional Study.
    Arita R; Morishige N; Koh S; Shirakawa R; Kawashima M; Sakimoto T; Suzuki T; Tsubota K
    Ophthalmology; 2015 May; 122(5):925-33. PubMed ID: 25626757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathophysiology of Meibomian Glands - An Overview.
    Dietrich J; Garreis F; Paulsen F
    Ocul Immunol Inflamm; 2021 May; 29(4):803-810. PubMed ID: 33945389
    [No Abstract]   [Full Text] [Related]  

  • 19. Review on the possible pathophysiological mechanisms underlying visual display terminal-associated dry eye disease.
    Fjaervoll K; Fjaervoll H; Magno M; Nøland ST; Dartt DA; Vehof J; Utheim TP
    Acta Ophthalmol; 2022 Dec; 100(8):861-877. PubMed ID: 35441459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TFOS DEWS II Diagnostic Methodology report.
    Wolffsohn JS; Arita R; Chalmers R; Djalilian A; Dogru M; Dumbleton K; Gupta PK; Karpecki P; Lazreg S; Pult H; Sullivan BD; Tomlinson A; Tong L; Villani E; Yoon KC; Jones L; Craig JP
    Ocul Surf; 2017 Jul; 15(3):539-574. PubMed ID: 28736342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.